Explore the role of preclinical MRI in studying neurological diseases, with a focus on advanced cellular and molecular ...
Researchers at the Broad Institute of MIT and Harvard have developed a gene-editing treatment for prion disease that extends ...
Discover the top stocks for the new year selected by Needham analysts, including ACV Auctions, Alcon, Alegro Microsystems, ...
More information: Meirui An et al, In vivo base editing extends lifespan of a humanized mouse model of prion disease, Nature Medicine (2025). DOI: 10.1038/s41591-024-03466-w . www.nature.com ...
Citi analyst David Lebowitz maintained a Buy rating on BridgeBio Pharma (BBIO – Research Report) yesterday and set a price target of ...
We think current levels (~$350M EV) are an attractive entry point, given that we model Voquezna (potassium ... to MECP2 overexpression or AAV (adeno-associated virus) administration.” ...
Syntekabio announced that it will participate in the 2025 JP Morgan Healthcare Conference and Biotech Showcase held in San Francisco on Jan. 13 (local time) to showcase its language model software ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback